The American Journal of Psychiatry devoted an entire issue to research on psychedelics.
Read moreLoneliness and Being Alone
We live in a bustling, crowded world, yet loneliness appears to be on the rise.
Why are so many of us feeling isolated and what can we do about it?
Read moreAyahuasca, Risks and Benefits
UCLA psychiatry professor Charles Grob discusses ayahuasca's risks, his research on the substance, and the growing need for new ayahuasca studies.
Read moreIs Time Real?
A British physicist working in solitude has produced work that challenges everything we thought we knew about time.
Julian Barbour, based in Oxfordshire, has spent over five decades developing a theory that redefines the nature of reality.
Read moreThe Future of MDMA Research
The Potential for Psychedelics as Medicine
This article from the APA looks at the potential of MDMA, ketamine, and psilocybin to help people with treatment-resistant mental health conditions.
Read moreDid the Psychedelic Research Bubble Burst?
The psychedelic renaissance is now at a point of reckoning, and the extraordinary promise of these drugs to quickly and easily transform lives for the better is starting to look more like a fever dream.
Read moreGroup Psychedelic Experiences and Success
Adverse Effects
This research study looks at the adverse effects in studies of psychedelics and MDMA.
Read morePsilocybin for Inner Healing Depression
The journey to healing from depression often demands more than just symptom management; it requires a deep, inner transformation that addresses the root of emotional distress.
This inner healing process is crucial for those suffering from depression, as it can lead to more profound and lasting recovery.
Read moreThree Studies of MDMA Treatment Retracted by Scientific Journal
The journal Psychopharmacology has retracted three papers about MDMA-assisted therapy based on what the publication said was unethical conduct at one of the study sites where the research took place.
Several of the papers’ authors are affiliated with Lykos Therapeutics, the drug company whose application for MDMA-assisted therapy to treat post-traumatic stress disorder was rejected last week by the Food and Drug Administration.
Read more